Rheumatoid Arthritis Drugs Market Trends

Rheumatoid Arthritis Drugs Market Focusing on Current Trends, Leading with Top Key Players: Eli Lilly and Company, Merck & Co., Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson

Rise in the prevalence of rheumatoid arthritis, surge in geriatric population, and transition from symptom management to slowing the progression of the disease are the major factors that drive the growth of the global rheumatoid arthritis drugs market. On the other hand, side effects associated with the medication and higher cost of biologics & biosimilars …

Continue reading “Rheumatoid Arthritis Drugs Market Focusing on Current Trends, Leading with Top Key Players: Eli Lilly and Company, Merck & Co., Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson”

Rheumatoid Arthritis Drugs Market Size, Share and Industry Growth

According to a new report published by Allied Market Research, titled, “Rheumatoid Arthritis Drugs Market: Global Opportunity Analysis and Industry Forecast, 2020–2027″ The global rheumatoid arthritis drugs market size was valued at $57,929 million in 2019, and is projected to reach $62,935 million by 2027, registering a CAGR of 2.8% from 2020 to 2027. Rheumatoid …

Continue reading “Rheumatoid Arthritis Drugs Market Size, Share and Industry Growth”